Join to access to all OVN content. Join for Free
Landing My First MSL Role: From the Inside
Amanda Vaughn Medical Science Liaison MSL career transition networking strategies in MSL interview preparation for MSL jobs

Landing My First MSL Role: From the Inside


Share This Article


Summary

In this episode, Amanda Vaughn joins the discussion to share her transition from academia to the industry and her new role as an MSL at Aglia. Amanda delves into the networking strategies that facilitated her move and the preparations she undertook for her onboarding. She provides insights into tackling interviews and standing out amidst competition in the MSL field. Amanda also offers key advice for aspiring MSLs, drawing from her academic background and previous radio experiences. The episode wraps up with reflections on Amanda's journey and a teaser for future episodes.

Amanda Vaughn, Medical Science Liaison at Aeglea BioTherapeutics shares the story of landing her first MSL job from an inside role within her company.

Amanda shares…

πŸ‘‰ How she landed her first role in the industry

πŸ‘‰ What she was doing to stand out in her role

πŸ‘‰ How she was able to land an interview and what she did to prepare

πŸ‘‰ How she was able to outshine the competition and land the job

πŸ‘‰ Lessons she learned and advice for others

Click for Source
Amanda Vaughn, Medical Science Liaison, MSL career transition, networking strategies in MSL, interview preparation for MSL jobs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Explore OVN